These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38370134)

  • 1. [Health alerts for substandard, falsified, and unregistered medical products at the onset of the COVID-19 pandemic in the AmericasAlertas de saúde para produtos médicos abaixo do padrão, falsificados e não registrados no início da pandemia de COVID-19 nas Américas].
    Gorordo M; Rojas-Cortés R; Carino J; Vahos Zambrano J; Castro JL
    Rev Panam Salud Publica; 2024; 48():e7. PubMed ID: 38370134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substandard, falsified and unregistered medicines in Latin America, 2017-2018.
    Rojas-Cortés R
    Rev Panam Salud Publica; 2020; 44():e125. PubMed ID: 33033498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Market surveillance and control of substandard, falsified and unregistered medicines: integrative reviewVigilancia y control de medicamentos subestándar, falsificados y no registrados: una revisión integral].
    Martins MAF; Scherer MDDA; Lucchese G
    Rev Panam Salud Publica; 2022; 46():e36. PubMed ID: 35520020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review.
    Asrade Mekonnen B; Getie Yizengaw M; Chanie Worku M
    J Pharm Policy Pract; 2024; 17(1):2375267. PubMed ID: 39015754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001-2011).
    Almuzaini T; Sammons H; Choonara I
    BMJ Open; 2013; 3(7):. PubMed ID: 23883882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substandard and falsified medical product recalls in Zambia from 2018 to 2021 and implications on the quality surveillance systems.
    Chabalenge B; Jere E; Nanyangwe N; Hikaambo C; Mudenda S; Banda M; Kalungia A; Matafwali S
    J Med Access; 2022; 6():27550834221141767. PubMed ID: 36601496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-Care Anti-Counterfeit Medicines Technologies: Awareness and Utilization among Medical Practitioners in Eastern Nigeria.
    Iloh GU; Akodu BA; Emeka EA; Obi IV
    West Afr J Med; 2021 Nov; Vol. 38(11):1029-1035. PubMed ID: 34918894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
    Petersen A; Held N; Heide L;
    PLoS One; 2017; 12(9):e0184165. PubMed ID: 28877208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country.
    Khurelbat D; Dorj G; Sunderland B; Sanjjav T; Bayarsaikhan E; Damdinjav D; Dorj G; Jigjidsuren A; Lkhagvasuren O; Erdenetsetseg B
    BMC Public Health; 2020 May; 20(1):743. PubMed ID: 32434489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance for substandard and falsified medicines by local faith-based organizations in 13 low- and middle-income countries using the GPHF Minilab.
    Gnegel G; Häfele-Abah C; Neci R; ; Heide L
    Sci Rep; 2022 Jul; 12(1):13095. PubMed ID: 35908047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives.
    Ahmed J; Modica de Mohac L; Mackey TK; Raimi-Abraham BT
    J Med Access; 2022; 6():23992026221074548. PubMed ID: 36204527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of drug recalls and quality of pharmaceutical products in Nepal.
    Neupane A; Bastakoti M; Tamang S; Giri B
    BMJ Open; 2022 Jul; 12(7):e053479. PubMed ID: 35788073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community.
    Kniazkov S; Dube-Mwedzi S; Nikiema JB
    J Pharm Policy Pract; 2020; 13():71. PubMed ID: 33088577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    Ozawa S; Evans DR; Bessias S; Haynie DG; Yemeke TT; Laing SK; Herrington JE
    JAMA Netw Open; 2018 Aug; 1(4):e181662. PubMed ID: 30646106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the COVID-19 pandemic on the quality of medical products in Zimbabwe: a qualitative study based on key informant interviews with health system stakeholders.
    Yemeke TT; Umaru FA; Ferrand RA; Ozawa S
    BMJ Open; 2023 Jun; 13(6):e068923. PubMed ID: 37290943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicine quality in high-income countries: The obstacles to comparative prevalence studies.
    Naughton BD; Akgul E
    Med Access Point Care; 2021; 5():23992026211052272. PubMed ID: 36204504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic cost of substandard and falsified human medicines and cosmetics with banned ingredients in Tanzania from 2005 to 2015: a retrospective review of data from the regulatory authority.
    Mori AT; Meena E; Kaale EA
    BMJ Open; 2018 Jun; 8(6):e021825. PubMed ID: 29950474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A narrative review of illegal online pharmacies and contemporary issues with restricting FDA-approved medication access.
    Jillani Z; Reinhard L; Hertig J
    J Med Access; 2023; 7():27550834231220512. PubMed ID: 38149839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.